Showing results (21-30 of 3,316) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|January 5, 2002
The efficacy and safety of risperidone for the treatment of geriatric psychosisJ P Hwang, C H Yang, H C Yu, et al.Journal of Clinical Psychopharmacology|January 5, 2002
Pharmacoepidemiologic investigation of a clonazepam-carbamazepine interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patientsE Yukawa, T Nonaka, M Yukawa, et al.Journal of Clinical Psychopharmacology|January 5, 2002
Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over studyY M Bai, C C Lin, J Y Chen, et al.Journal of Clinical Psychopharmacology|January 5, 2002
Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind studyT Fischel, H Hermesh, D Aizenberg, et al.Journal of Clinical Psychopharmacology|May 15, 2002
Fluoxetine alone in the treatment of first episode anxious-depression: an open clinical trialGianfranco Spalletta, Augusto Pasini, Carlo CaltagironeJournal of Clinical Psychopharmacology|May 15, 2002
Interactive model of therapeutic response in panic disorder: moclobemide, a case in pointE H Uhlenhuth, Teddy D Warner, William MatuzasJournal of Clinical Psychopharmacology|August 13, 2002
Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorderHoward C Margolese, Guy Chouinard, Linda Beauclair, et al.Journal of Clinical Psychopharmacology|August 13, 2002
Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trialsStephen M Stahl, Joseph Mendels, Gerri E SchwartzJournal of Clinical Psychopharmacology|July 31, 2001
A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorderP G Janicak, P E Keck, J M Davis, et al.Journal of Clinical Psychopharmacology|July 31, 2001
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin AmericaJ A Costa e Silva, N Alvarez, G Mazzotti, et al.Pageof 332